
Bluejay Diagnostics
(NASDAQ) BJDX
Bluejay Diagnostics Financials at a Glance
Market Cap
$3.03M
Revenue (TTM)
$0.00
Net Income (TTM)
-$6.90M
EPS (TTM)
-$14.02
P/E Ratio
-0.21
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.43
Volume
2,832,721.576
Open
$2.91
Price
$1.43
Volume
2,832,721.576
Open
$2.91
Previous Close
$1.44
Daily Range
$1.13 - $2.91
52-Week Range
$1.13 - $16.68
Estimated Earnings Date
Aug 19, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.43
Volume
2,832,721.576
Open
$2.91
Previous Close
$1.44
Daily Range
$1.13 - $2.91
52-Week Range
$1.13 - $16.68
Estimated Earnings Date
Aug 19, 2026
BJDX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bluejay Diagnostics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
6
CEO
Indranil Dey, PhD, MBA
Website
www.bluejaydx.comHeadquarters
Acton, MA 01720, US
BJDX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-144.27%
Return on Capital
-114.07%
Return on Assets
-123.30%
Earnings Yield
-4.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.03M
Shares Outstanding
1.03M
Volume
2.83M
Avg. Volume
1.30M
Financials (TTM)
Gross Profit
-$98.37K
Operating Income
-$7.00M
EBITDA
-$6.73M
Operating Cash Flow
-$6.46M
Capital Expenditure
-$192.74K
Free Cash Flow
-$6.65M
Cash & ST Invst.
$3.68M
Total Debt
$97.03K
Bluejay Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$49.56K
N/A
Gross Margin
0.00%
N/A
Market Cap
$3.03M
N/A
Market Cap/Employee
$433.10K
N/A
Employees
7
N/A
Net Income
-$1.92M
-2.9%
EBITDA
-$1.87M
-3.2%
Quarterly Fundamentals
Total Cash
$3.68M
+18.2%
Total Debt
$97.03K
-48.2%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$97.03K
-3.0%
Return on Assets
-1.23%
N/A
Return on Invested Capital
-1.67%
N/A
Free Cash Flow
-$1.61M
-35.7%
Operating Cash Flow
-$1.59M
-34.1%